LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU=Sinha Surabhi
  2. AU="K Siaw-Acheampong"
  3. AU="Ni, Zhao-Hui"
  4. AU="Sanderson, J. Thomas"
  5. AU="Raynaud, F I"
  6. AU="Jin, Di"
  7. AU="Raguzin, E" AU="Raguzin, E"
  8. AU="Rico, Alex"
  9. AU="Grinspan, Judith B"
  10. AU="Doerler, M"
  11. AU="Nyland, P"
  12. AU="Rana, Jigyasa"
  13. AU="Fennimore, Laura"
  14. AU="Blankstein, Kenneth"
  15. AU="O' Callaghan, Carol"
  16. AU="Van Snick, Jacques"
  17. AU="Yao, Xiaobin"
  18. AU="Georg Häcker"
  19. AU="Jain, S."
  20. AU="Alfakir, Razan"
  21. AU="Sozbilir, U."
  22. AU=Zhang Shuanghong
  23. AU="Iwama, Hisakazu"
  24. AU="Gomes, Andreia"
  25. AU="Machuca, Víctor"
  26. AU=Liu Nanyang AU=Liu Nanyang
  27. AU="Boudina, Sihem"
  28. AU="Ma, DongXue"
  29. AU="Bellucci, Margherita"
  30. AU="Prima, Musharrat Jahan"
  31. AU="Saiegh, Fadi Al"
  32. AU="Yang, Deok-Chun"
  33. AU="Arima, Hisatomi"
  34. AU=Czubak Jacek
  35. AU="de Melo, Bruna Oliveira"
  36. AU="Sokhadze, Guela"
  37. AU="Meuleman, Philip"
  38. AU=Mishra Arnab Kumar AU=Mishra Arnab Kumar
  39. AU="Linda A. Gleaves"
  40. AU="Vandelli, Maria Angela"
  41. AU="Guerrera, Luigi Pio"
  42. AU="Sabitri Lamichhane"
  43. AU="Echevarria, Marco"
  44. AU="Yanmin Li"

Suchergebnis

Treffer 1 - 10 von insgesamt 118

Suchoptionen

  1. Buch ; Online ; E-Book: Skin diseases in females

    Sarkar, Rashmi / Sinha, Surabhi

    2022  

    Verfasserangabe Rashmi Sarkar, Surabhi Sinha, editors
    Mesh-Begriff(e) Skin Diseases ; Women's Health. ; Cosmetic techniques.
    Schlagwörter Skin/Diseases ; Women/Health and hygiene
    Thema/Rubrik (Code) 616.5
    Sprache Englisch
    Erscheinungsverlauf 2022-2022
    Umfang 1 online resource (603 pages) :, illustrations
    Verlag Springer
    Erscheinungsort Singapore
    Dokumenttyp Buch ; Online ; E-Book
    Bemerkung Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 981-16-6065-4 ; 9789811660641 ; 978-981-16-6065-8 ; 9811660646
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Kategorien

  2. Buch: Skin Diseases in Females

    Sinha, Surabhi / Sarkar, Rashmi

    2022  

    Verfasserangabe Dr. Rashmi Sarkar ,MD,FAMS, works as a Director Professor of Dermatology at Lady Hardinge Medical College and Associated Hospitals, Delhi University, New Delhi, India. She has done her MD (Dermatology) from the Postgraduate Institute of Medical Education and Research, Chandigarh, India. Her special interests are pigmentary disorders and pediatric dermatology. She is Editor in Chief,Pigment International . She has edited 16 books, has 200 publications and 80 textbook chapters.She Is President IADVL 2022 and Vice President ,International Society of Dermatology.A well known national and international speaker for two decades, been awarded with Member making a Difference Award(AAD),Dr B.M Ambady Oration and Dr V.N.Sehgal Award for Excellence in Dermatology from IADVL. Dr. Surabhi Sinha, MD, DNB presently works as a Senior Specialist (CHS) and Associate Professor in the Department of Dermatology at Dr. Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences (
    Schlagwörter ageing ; Women ; pregnancy ; Menopause ; Skin diseases ; Pregnancy ; Ageing
    Sprache Englisch
    Umfang 624 p.
    Ausgabenhinweis 1
    Verlag Springer Nature Singapore
    Dokumenttyp Buch
    Anmerkung PDA Manuell_17
    Format 160 x 241 x 37
    ISBN 9789811660641 ; 9811660646
    Datenquelle PDA

    Kategorien

  3. Artikel ; Online: Sequential occurrence of upgrading and downgrading type 1 leprosy reactions: A case report.

    Sharath, Savitha / Sinha, Surabhi / Sardana, Kabir / Ahuja, Arvind

    Tropical doctor

    2024  Band 54, Heft 2, Seite(n) 185–188

    Mesh-Begriff(e) Humans ; Leprosy/diagnosis
    Sprache Englisch
    Erscheinungsdatum 2024-02-14
    Erscheinungsland England
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 193169-6
    ISSN 1758-1133 ; 0049-4755
    ISSN (online) 1758-1133
    ISSN 0049-4755
    DOI 10.1177/00494755241229754
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Reactive Arthritis Following Vaccination against COVID-19: An Unexpected Adverse Reaction.

    Agrawal, Diksha / Sinha, Surabhi / Dabas, Srishti / Malhotra, Purnima

    Indian dermatology online journal

    2023  Band 14, Heft 3, Seite(n) 424–426

    Sprache Englisch
    Erscheinungsdatum 2023-04-04
    Erscheinungsland India
    Dokumenttyp Journal Article
    ZDB-ID 2585814-2
    ISSN 2249-5673 ; 2229-5178
    ISSN (online) 2249-5673
    ISSN 2229-5178
    DOI 10.4103/idoj.idoj_338_22
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Recent advances of decatungstate photocatalyst in HAT process.

    Singh, Praveen P / Sinha, Surabhi / Gahtori, Prashant / Tivari, Shraddha / Srivastava, Vishal

    Organic & biomolecular chemistry

    2024  Band 22, Heft 13, Seite(n) 2523–2538

    Abstract: The decatungstate anion ( ... ...

    Abstract The decatungstate anion (W
    Sprache Englisch
    Erscheinungsdatum 2024-03-27
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2097583-1
    ISSN 1477-0539 ; 1477-0520
    ISSN (online) 1477-0539
    ISSN 1477-0520
    DOI 10.1039/d4ob00213j
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel: Evaluation of comorbidities in the SARS-CoV-2-related mortalities: A retrospective observation from a dedicated COVID-19 care hospital.

    Khanna, Nisha / Bharti, Shreekant / Guralarasan, G / Surabhi / Kumar, Tarun / Sinha, Ruchi / Bhadani, Punam P

    Journal of family medicine and primary care

    2024  Band 13, Heft 2, Seite(n) 585–588

    Abstract: Since its discovery in Wuhan, China, in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the world with being declared a pandemic in March 2020 by the World Health Organization (WHO). Comorbidities ...

    Abstract Since its discovery in Wuhan, China, in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the world with being declared a pandemic in March 2020 by the World Health Organization (WHO). Comorbidities are one of the most concerning clinical considerations for mortality.
    Materials and methods: This was a retrospective observational study conducted at the All India Institute of Medical Sciences in Patna, Bihar, from June 2020 to December 2020. It included adult patients who succumbed to coronavirus disease 2019 (COVID-19) during this period, and their relevant information, such as demographic information hospital stay duration, haematological parameters and comorbidities, was gathered.
    Results: The mean age of the study group was 63.5 (11.8) years. Of 150 cases, 126 men (about 84 per cent) and 24 women were involved (16 per cent). In our study, hypertension (HTN) was shown to be the most frequent comorbidity at 68.7% (103/150), followed by diabetes mellitus (DM) at 61.3% (92/150). The most prevalent haematological disorder identified in our investigation was anaemia and leucocytosis.
    Conclusion: The categorisation of patients who would need extra measures including early hospitalisation, heightened monitoring and intense therapy would be made easier by identifying patient traits and conditions.
    Sprache Englisch
    Erscheinungsdatum 2024-03-06
    Erscheinungsland India
    Dokumenttyp Journal Article
    ZDB-ID 2735275-4
    ISSN 2278-7135 ; 2249-4863
    ISSN (online) 2278-7135
    ISSN 2249-4863
    DOI 10.4103/jfmpc.jfmpc_2404_22
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: Ultrasound-guided bilateral continuous pecto-intercostal fascial block for post-sternotomy pain management.

    Kumar, Amarjeet / Sinha, Chandni / Kumar, Ajeet / Krishna, Kunal / Prakash, Abhinav / Surabhi

    Journal of anaesthesiology, clinical pharmacology

    2023  Band 39, Heft 4, Seite(n) 656–657

    Sprache Englisch
    Erscheinungsdatum 2023-12-20
    Erscheinungsland India
    Dokumenttyp Journal Article
    ZDB-ID 1401760-x
    ISSN 0970-9185
    ISSN 0970-9185
    DOI 10.4103/joacp.joacp_38_22
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Moderate Elevation of Homocysteine Induces Endothelial Dysfunction through Adaptive UPR Activation and Metabolic Rewiring.

    Chatterjee, Barun / Fatima, Fabeha / Seth, Surabhi / Sinha Roy, Soumya

    Cells

    2024  Band 13, Heft 3

    Abstract: Elevation of the intermediate amino acid metabolite Homocysteine (Hcy) causes Hyperhomocysteinemia (HHcy), a metabolic disorder frequently associated with mutations in the methionine-cysteine metabolic cycle as well as with nutritional deficiency and ... ...

    Abstract Elevation of the intermediate amino acid metabolite Homocysteine (Hcy) causes Hyperhomocysteinemia (HHcy), a metabolic disorder frequently associated with mutations in the methionine-cysteine metabolic cycle as well as with nutritional deficiency and aging. The previous literature suggests that HHcy is a strong risk factor for cardiovascular diseases. Severe HHcy is well-established to correlate with vascular pathologies primarily via endothelial cell death. Though moderate HHcy is more prevalent and associated with an increased risk of cardiovascular abnormalities in later part of life, its precise role in endothelial physiology is largely unknown. In this study, we report that moderate elevation of Hcy causes endothelial dysfunction through impairment of their migration and proliferation. We established that unlike severe elevation of Hcy, moderate HHcy is not associated with suppression of endothelial VEGF/VEGFR transcripts and ROS induction. We further showed that moderate HHcy induces a sub-lethal ER stress that causes defective endothelial migration through abnormal actin cytoskeletal remodeling. We also found that sub-lethal increase in Hcy causes endothelial proliferation defect by suppressing mitochondrial respiration and concomitantly increases glycolysis to compensate the consequential ATP loss and maintain overall energy homeostasis. Finally, analyzing a previously published microarray dataset, we confirmed that these hallmarks of moderate HHcy are conserved in adult endothelial cells as well. Thus, we identified adaptive UPR and metabolic rewiring as two key mechanistic signatures in moderate HHcy-associated endothelial dysfunction. As HHcy is clinically associated with enhanced vascular inflammation and hypercoagulability, identifying these mechanistic pathways may serve as future targets to regulate endothelial function and health.
    Mesh-Begriff(e) Humans ; Endothelial Cells/metabolism ; Homocysteine/metabolism ; Cell Death ; Vascular Diseases/metabolism ; Cardiovascular Diseases/metabolism
    Chemische Substanzen Homocysteine (0LVT1QZ0BA)
    Sprache Englisch
    Erscheinungsdatum 2024-01-24
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells13030214
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Impaired Fibroblast Growth Factor 21 (FGF21) Associated with Visceral Adiposity Leads to Insulin Resistance: The Core Defect in Diabetes Mellitus.

    Jain, Unnati / Srivastava, Priyanka / Sharma, Ashwani / Sinha, Subrata / Johari, Surabhi

    Current diabetes reviews

    2024  

    Abstract: The Central nervous system (CNS) is the prime regulator of signaling pathways whose function includes regulation of food intake (consumption), energy expenditure, and other metabolic responses like glycolysis, gluconeogenesis, fatty acid oxidation, and ... ...

    Abstract The Central nervous system (CNS) is the prime regulator of signaling pathways whose function includes regulation of food intake (consumption), energy expenditure, and other metabolic responses like glycolysis, gluconeogenesis, fatty acid oxidation, and thermogenesis that have been implicated in chronic inflammatory disorders. Type 2 diabetes mellitus (T2DM) and obesity are two metabolic disorders that are linked together and have become an epidemic worldwide, thus raising significant public health concerns. Fibroblast growth factor 21 (FGF21) is an endocrine hormone with pleiotropic metabolic effects that increase insulin sensitivity and energy expenditure by elevating thermogenesis in brown or beige adipocytes, thus reducing body weight and sugar intake. In contrast, during starvation conditions, FGF21 induces its expression in the liver to initiate glucose homeostasis. Insulin resistance is one of the main anomalies caused by impaired FGF21 signaling, which also causes abnormal regulation of other signaling pathways. Tumor necrosis factor alpha (TNF-α), the cytokine released by adipocytes and inflammatory cells in response to chronic inflammation, is regarded major factor that reduces the expression of FGF21 and modulates underlying insulin resistance that causes imbalanced glucose homeostasis. This review aims to shed light on the mechanisms underlying the development of insulin resistance in obese individuals as well as the fundamental flaw in type 2 diabetes, which is malfunctioning obese adipose tissue.
    Sprache Englisch
    Erscheinungsdatum 2024-04-26
    Erscheinungsland United Arab Emirates
    Dokumenttyp Journal Article
    ISSN 1875-6417
    ISSN (online) 1875-6417
    DOI 10.2174/0115733998265915231116043813
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Relapsing donovanosis rhyming with unexplained decline in CD4 count in a person living with HIV/AIDS: Long-term follow up and therapeutic outcome.

    Sinha, Surabhi / Sardana, Kabir / Agarwal, Aastha / Ahuja, Arvind

    International journal of STD & AIDS

    2023  Band 34, Heft 6, Seite(n) 423–426

    Abstract: Donovanosis is a chronic genital ulcerative disease caused by the intracellular Gram-negative bacterium Klebsiella granulomatis, reported more frequently in people living with HIV/AIDS (PLHA). Here we present a case of relapsing donovanosis in a PLHA on ... ...

    Abstract Donovanosis is a chronic genital ulcerative disease caused by the intracellular Gram-negative bacterium Klebsiella granulomatis, reported more frequently in people living with HIV/AIDS (PLHA). Here we present a case of relapsing donovanosis in a PLHA on second line antiretroviral therapy who had episodes of transient unexplained decrease in CD4 counts associated with rapid growth of the lesion and non-responsiveness to treatment followed by clinical resolution coinciding with recovery of the CD4 count.
    Mesh-Begriff(e) Humans ; Granuloma Inguinale/drug therapy ; Acquired Immunodeficiency Syndrome/complications ; Follow-Up Studies ; CD4 Lymphocyte Count ; Treatment Outcome
    Sprache Englisch
    Erscheinungsdatum 2023-02-20
    Erscheinungsland England
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 1018089-8
    ISSN 1758-1052 ; 0956-4624
    ISSN (online) 1758-1052
    ISSN 0956-4624
    DOI 10.1177/09564624231156205
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang